To obtain better predictions of the disease outcome in thyroid carcinoma, many immunohistochemical markers have been studied to find suitable tools; ki67 is considered to be a promising tool for evaluating cell proliferation. This evidence concerns the gene MKI67 and thyroid gland carcinoma.